4 INTERVENČNÍ A AKUTNÍ KARDIOLOGIE www.iakardiologie.cz OBSAH MONOTEMATICKÉ ČÍSLO: MITRÁLNÍ CHLOPEŇ MONOTHEMATIC ISSUE: MITRAL VALVE editoři / editors: doc. MUDr. Petr Kala, Ph.D., FESC, FSCAI, prof. MUDr. Jan Vojáček, Ph.D. SLOVO ÚVODEM / EDITORS’ FOREWORD 7 Petr Kala, Jan Vojáček Slovo úvodem Editors’ foreword PŘEHLEDOVÉ ČLÁNKY / REVIEW ARTICLES 8 Petr Lokaj Patofyziologie mitrální regurgitace Pathophysiology of mitral regurgitation 12 Pavel Žáček Chirurgická léčba mitrální nedomykavosti jako zlatý standard Surgical treatment of mitral incompetence as a gold standard For professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable). Edwards Lifesciences devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity. Edwards, Edwards Lifesciences, the stylized E logo, Edwards SAPIEN, Edwards SAPIEN 3, Edwards SAPIEN 3 Ultra, SAPIEN, SAPIEN 3, and SAPIEN 3 Ultra are trademarks of Edwards Lifesciences Corporation or its affiliates. All other trademarks are the property of their respective owners. © 2021 Edwards Lifesciences Corporation. All rights reserved. PP--EU-3155 v1.0 Edwards Lifesciences • Route de L’Etraz 70, 1260 Nyon, Switzerland • edwards.com Protect your patients by preserving their future treatment options with SAPIEN 3 Ultra TAVI. Learn more at YourHigherStandard.com You’re always thinking ahead. We can get behind that. Edwards SAPIEN 3 Ultra TAVI facilitates future coronary access. Edwards SAPIEN 3 Ultra valve
RkJQdWJsaXNoZXIy NDA4Mjc=